Nosocomial Acquisition of Clostridium difficile Infection

New England Journal of Medicine

Volumn 320, Issue 4, 1989, Pages 204-210

  Mcfarland, Lynne V ^a   Mulligan, Maury E ^b   Kwok, Richard Y y ^b   Stamm, Walter E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIUM DIFFICILE; DIARRHEA; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL;

EID: 0024545882     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198901263200402     Document Type: Article

References (32)

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978; 298: 531–4.
2. Pierce PF Jr, Wilson R, Silva J Jr, et al. Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis 1982; 145: 269–74.
3. Tabaqchali S, Holland D, O'Farrell S, Silman R. Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies. Lancet 1984; 1: 935–8.
4. Nolan NP, Kelly CP, Humphreys JF, et al. An epidemic of pseudomembranous colitis: importance of person to person spread. Gut 1987; 28: 1467–73.
5. Heard SR, Wren B, Barnett MJ, Thomas JM, Tabaqchali S. Clostridium difficile infection in patients with haematological malignant disease: risk factors, faecal toxins and pathogenic strains. Epidemiol Infect 1988; 100: 63–72.
6. Heard SR, O'Farrell S, Holland D, Crook S, Barnett MJ, Tabaqchali S. The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. J Infect Dis 1986; 153: 159–62.
7. Savage AM, Alford RH. Nosocomial spread of C. difficile. Infect Control 1983; 4: 31–3.
8. Malamou-Ladas H, O'Farrell S, Nash JQ, Tabaqchali S. Isolation of Clostridium difficile from patients and the environment of hospital wards. J Clin Pathol 1983; 36: 88–92.
9. Mulligan ME, George WL, Rolfe RD, Finegold SM. Epidemiological aspects of Clostridium difficile-induced diarrhea and colitis. Am J Clin Nutr 1980; 33: Suppl 11: 2533–8.
10. Mulligan ME, Rolfe RD, Finegold SM, George WL. Contamination of a hospital environment by Clostridium difficile. Curr Microbiol 1979; 3: 173–5.
11. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981; 143: 42–50.
12. Horn SD, Sharkey PD, Bertram DA. Measuring severity of illness: homogeneous case mix groups. Med Care 1983; 21: 14–30.
13. Willey SH, Bartlett JG. Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin. J Clin Microbiol 1979; 10: 880–4.
14. Garner JS, Simmons BP. CDC guidelines for the prevention and control of nosocomial infections: guideline for isolation precautions in hospitals. Am J Infect Control 1984; 12: 103–30.
15. Gebhard RL, Gerding DN, Olson MM, et al. Clinical and endoscopic findings in patients early in the course of Clostridium difficile-associated pseudomembranous colitis. Am J Med 1985; 78: 45–8.
16. McFarland LV, Stamm WE. Review of Clostridium difficile-associated diseases. Am J Infect Control 1986; 14: 99–109.
17. McFarland LV, Coyle MB, Kremer WH, Stamm WE. Rectal swab cultures for Clostridium difficile surveillance studies. J Clin Microbiol 1987; 25: 2241–2.
18. Bate G. Comparison of Minitek Anaerobe II, API An-Ident, and RapID ANA systems for identification of Clostridium difficile. Am J Clin Pathol 1986; 85: 716–8.
19. Mulligan ME, Peterson LR, Kwok RY, Clabots CR, Gerding DN. Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel eiectrophoresis for typing Clostridium difficile. J Clin Microbiol 1988; 26: 41–6.
20. Riley TV, Bowman RA, Carroll SM. Diarrhoea associated with Clostridium difficile in a hospital population. Med J Aust 1983; 1: 166–9.
21. Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis in adults: a prospective case-controlled epidemiologic study. Arch Intern Med 1986; 146: 95–100.
22. Pantosti A, Cerquetti M, Gianfrilli PM. Electrophoretic characterization of Clostridium difficile strains isolated from antibiotic-associated colitis and other conditions. J Clin Microbiol 1988; 26: 540–3.
23. Aronsson B, Mollby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980–1982. J Infect Dis 1985; 151: 476–81.
24. Fekety R, Kim KH, Brown D, Batts DH, Cudmore M, Silva J Jr. Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment. Am J Med 1981; 70: 906–8.
25. Walters BA, Stafford R, Roberts RK, Seneviratne E. Contamination and crossinfection with Clostridium difficile in an intensive care unit. Aust NZ J Med 1982; 12: 255–8.
26. Al-Jumaili IJ, Shibley M, Lishman AH, Record CO. Incidence and origin of Clostridium difficile in neonates. J Clin Microbiol 1984; 19: 77–8.
27. Larson HE, Price AB, Borriello SP. Epidemiology of experimental enterocecitis due to Clostridium difficile. J Infect Dis 1980; 142: 408–13.
28. Fekety R. Kim K-H, Batts DH, et al. Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis. Am J Clin Nutr 1980; 33: Suppl 11: 2527–32.
29. Larson HE, Barclay FE, Honour P, Hill ID. Epidemiology of Clostridium difficile in infants. J Infect Dis 1982; 146: 727–33.
30. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988; 127: 1289–94.
31. Bender BS, Bennett R, Laughon BE, et al. Is Clostridium difficile endemic in chronic-care facilities? Lancet 1986; 2: 11–3.
32. Lynch P, Jackson MM, Cummings MJ, Stamm WE. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med 1987; 107: 243–6.